Preventing type 2 diabetes with low-dose combinations.
Buchanan
Thomas A
TA
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 91011, USA. buchanan@usc.edu
Xiang
Anny H
AH
D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008687:Metformin / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000009:adverse effects
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin